![Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma. - Abstract - Europe PMC Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3818940/bin/oaju-3-069Fig2.jpg)
Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma. - Abstract - Europe PMC
![Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram](https://www.researchgate.net/publication/26767509/figure/fig2/AS:202820637728778@1425367616886/Mechanism-of-action-of-sorafenib-Sorafenib-exerts-a-dual-anticancer-effect-on-the-tumor.png)
Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram
![Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram](https://www.researchgate.net/publication/260429966/figure/fig2/AS:271829853052928@1441820695259/Sorafenib-mechanism-of-action-tumor-proliferation-and-angiogenesis-Adapted-from-Mol.png)
Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram
![Mechanism of action of bevacizumab, sorafenib, and sunitinib. Diagram... | Download Scientific Diagram Mechanism of action of bevacizumab, sorafenib, and sunitinib. Diagram... | Download Scientific Diagram](https://www.researchgate.net/publication/261915893/figure/fig1/AS:973940793036801@1609216988750/Mechanism-of-action-of-bevacizumab-sorafenib-and-sunitinib-Diagram-of-the-signaling.png)
Mechanism of action of bevacizumab, sorafenib, and sunitinib. Diagram... | Download Scientific Diagram
![Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523419305975-fx1.jpg)
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect
![The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-020-0187-x/MediaObjects/41392_2020_187_Fig4_HTML.png)
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
![TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma - Lai - 2019 - Molecular Oncology - Wiley Online Library TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma - Lai - 2019 - Molecular Oncology - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/9fd93f20-881e-409a-8cdd-8f2ddf13c8c1/mol212449-fig-0007-m.jpg)
TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma - Lai - 2019 - Molecular Oncology - Wiley Online Library
![Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma. - Abstract - Europe PMC Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6689804/bin/WJG-25-3870-g002.jpg)
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma. - Abstract - Europe PMC
![Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis | Journal of Experimental & Clinical Cancer Research | Full Text Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-020-1528-x/MediaObjects/13046_2020_1528_Fig7_HTML.png)
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis | Journal of Experimental & Clinical Cancer Research | Full Text
![The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-020-0187-x/MediaObjects/41392_2020_187_Fig5_HTML.png)
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
![Potential mechanisms of action of Sorafenib in RCC. Note: Sorafenib can... | Download Scientific Diagram Potential mechanisms of action of Sorafenib in RCC. Note: Sorafenib can... | Download Scientific Diagram](https://www.researchgate.net/publication/314398359/figure/fig1/AS:470040974761985@1489077909939/Potential-mechanisms-of-action-of-Sorafenib-in-RCC-Note-Sorafenib-can-inhibit-both.png)
Potential mechanisms of action of Sorafenib in RCC. Note: Sorafenib can... | Download Scientific Diagram
![Mechanisms of sorafenib resistance. Sorafenib as an anticancer drug is... | Download Scientific Diagram Mechanisms of sorafenib resistance. Sorafenib as an anticancer drug is... | Download Scientific Diagram](https://www.researchgate.net/publication/342189897/figure/fig1/AS:905661965684736@1592938047846/Mechanisms-of-sorafenib-resistance-Sorafenib-as-an-anticancer-drug-is-transported-into_Q640.jpg)
Mechanisms of sorafenib resistance. Sorafenib as an anticancer drug is... | Download Scientific Diagram
![Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors | Experimental & Molecular Medicine Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors | Experimental & Molecular Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs12276-018-0159-1/MediaObjects/12276_2018_159_Fig1_HTML.png)
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors | Experimental & Molecular Medicine
![IJMS | Free Full-Text | Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment | HTML IJMS | Free Full-Text | Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment | HTML](https://www.mdpi.com/ijms/ijms-20-04712/article_deploy/html/images/ijms-20-04712-g001.png)
IJMS | Free Full-Text | Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment | HTML
![Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status](https://www.spandidos-publications.com/article_images/ijo/55/5/IJO-55-05-1069-g00.jpg)
Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
![Figure 1 from New knowledge of the mechanisms of sorafenib resistance in liver cancer | Semantic Scholar Figure 1 from New knowledge of the mechanisms of sorafenib resistance in liver cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2f0e82390bcc2faa1bc6a700b06f5db1d5fa2283/2-Figure1-1.png)
Figure 1 from New knowledge of the mechanisms of sorafenib resistance in liver cancer | Semantic Scholar
![Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523419305975-gr2.jpg)
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect
![Medicina | Free Full-Text | Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib Medicina | Free Full-Text | Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib](https://www.mdpi.com/medicina/medicina-55-00707/article_deploy/html/images/medicina-55-00707-g001.png)
Medicina | Free Full-Text | Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
![New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Faps.2017.5/MediaObjects/41401_2017_Article_BFaps20175_Fig1_HTML.jpg)